Trial Suspension is a regulatory action within the domain of clinical trial oversight that entails the temporary halting of a clinical trial, typically initiated by a sponsor, investigator, institutional review board, or regulatory authority, due to concerns regarding participant safety, protocol violations, or significant deviations from authorized procedures, thereby distinguishing it from permanent trial termination or routine pausing of recruitment.